Chordoma: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen (copyedits) |
imported>Daniel Mietchen (slight expansion) |
||
| Line 3: | Line 3: | ||
A '''chordoma''' (also known as choroid meningioma, chordocarcinoma, chordoepithelioma, or notochordoma) is a [[malignant tumor]] arising from the [[embryonic development|embryonic]] remains of the [[notochord]].<ref name=MeSH>{{MeSH}}</ref> | A '''chordoma''' (also known as choroid meningioma, chordocarcinoma, chordoepithelioma, or notochordoma) is a [[malignant tumor]] arising from the [[embryonic development|embryonic]] remains of the [[notochord]].<ref name=MeSH>{{MeSH}}</ref> | ||
Such malformations can occur anywhere in the bony tissue surrounding the [[spinal cord]], though typically at | Such malformations can occur anywhere in the bony tissue surrounding the [[spinal cord]], though typically its mobile parts at the [[cranial]] or [[caudal]] end. The [[prevalence]] is about 1 in a million in the United States. | ||
At least one [[susceptibility gene]] has been identified<ref name=Yang2009>{{CZ:Ref:Yang 2009 T (brachyury) gene duplication confers major susceptibility to familial chordoma}}</ref> but currently, no therapy is in sight, leaving affected patients with an average life expectancy of five to ten years after diagnosis. | At least one [[susceptibility gene]] has been identified<ref name=Yang2009>{{CZ:Ref:Yang 2009 T (brachyury) gene duplication confers major susceptibility to familial chordoma}}</ref> but currently, no therapy is in sight, leaving affected patients with an average life expectancy of five to ten years after diagnosis. | ||
Revision as of 06:18, 12 May 2010
A chordoma (also known as choroid meningioma, chordocarcinoma, chordoepithelioma, or notochordoma) is a malignant tumor arising from the embryonic remains of the notochord.[1]
Such malformations can occur anywhere in the bony tissue surrounding the spinal cord, though typically its mobile parts at the cranial or caudal end. The prevalence is about 1 in a million in the United States.
At least one susceptibility gene has been identified[2] but currently, no therapy is in sight, leaving affected patients with an average life expectancy of five to ten years after diagnosis.
References
- ↑ Anonymous (2024), Chordoma (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S et al. (2009). "T (brachyury) gene duplication confers major susceptibility to familial chordoma". Nat Genet 41 (11): 1176-8. DOI:10.1038/ng.454. PMID 19801981. Research Blogging. [e]
- Based on comparative genomic hybridization data from four affected families, variations in the 6q27 region of the human chromosome 6 were found to be correlated with chordoma, thus suggesting the T gene as a potential susceptibility gene for the disease.